A 16-week trial involving children with type 1 diabetes (T1D) found glucose level was in the target range for a greater percentage of time in individuals who used a closed-loop system compared with ...

Smart implants and closed-loop systems are at the forefront of precision healthcare, enabling real-time diagnostics and ...

The possible advantage of hybrid closed-loop therapy (i.e., artificial pancreas) over sensor-augmented pump therapy in very young children with type 1 diabetes is unclear. In this multicenter, ...

A closed-loop system of insulin delivery (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes. In a 16-week, multicenter, randomized, open-label, ...